
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc. demonstrates positive financial growth as evidenced by a sequential commercial pricing increase of 2.2%, which signals strong demand for its services. The company's Industrial Injury Prevention (IIP) revenue experienced a notable growth of 22.2%, with an 18.4% increase when excluding acquisitions, highlighting its operational strength and market positioning. Additionally, the successful integration of the recently acquired Metro business is reflected in the increased net rate, rising from approximately $101 to $107.50, further enhancing the firm's revenue potential.
Bears say
US Physical Therapy's recent financial metrics show a decline of 0.6% in its key revenue figure, positioning it at $83.95 compared to $84.46 in the same period last year. The company has been experiencing ongoing reimbursement cuts for five consecutive years, cumulatively impacting profitability by approximately $20 million, which adds significant pressure to their financial stability. Additionally, operational expenses, particularly rent and clinic-related costs, were slightly higher than anticipated at 20.2% of revenue, suggesting potential challenges in managing operational efficiency amid a constricting revenue environment.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares